We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
SiriusXM
SIRI
$10.4B
| $39.8M | 0.1% |
+678,439
| New | +$38M |
|
227
KLA
KLAC
$255B
| $39.7M | 0.1% |
2,043,700
-3,419,860
| -63% | -$58.5M |
|
228
Cabaletta Bio
CABA
$452M
| $39.7M | 0.1% |
3,565,009
-39,751
| -1% | -$304K |
|
229
Stanley Black & Decker
SWK
$15.5B
| $39.5M | 0.1% |
283,279
+56,647
| +25% | +$6.83M |
|
230
FedEx
FDX
$74.1B
| $39.2M | 0.1% |
279,304
-35,076
| -11% | -$4.41M |
|
231
Protagonist Therapeutics
PTGX
$8.73B
| $38.9M | 0.1% |
+2,200,000
| New | +$27.6M |
|
232
Vulcan Materials
VMC
$36.9B
| $38.6M | 0.1% |
333,559
-925,313
| -74% | -$101M |
|
233
Morgan Stanley
MS
$341B
| $38.6M | 0.1% |
798,656
-160,635
| -17% | -$6.75M |
|
234
Nutrien
NTR
$32.1B
| $38.5M | 0.1% |
1,200,000
-350,000
| -23% | -$12.2M |
|
235
Pinnacle West Capital
PNW
$12.3B
| $38.5M | 0.1% |
525,063
+397,700
| +312% | +$30M |
|
236
Canadian Natural Resources
CNQ
$96.3B
| $38.3M | 0.1% |
4,492,400
+4,390,300
| +4,300% | +$35.5M |
|
237
United Parcel Service
UPS
$92.7B
| $38.3M | 0.1% |
344,689
-210,800
| -38% | -$21M |
|
|
NBL
238
DELISTED
Noble Energy, Inc.
NBL
| $37.6M | 0.1% |
4,197,202
-5,498,481
| -57% | -$49.1M |
|
239
Viavi Solutions
VIAV
$9.95B
| $37.2M | 0.1% |
2,917,851
+1,063,851
| +57% | +$12.8M |
|
240
Xcel Energy
XEL
$48.6B
| $37.1M | 0.1% |
+594,200
| New | +$37.4M |
|
241
Republic Services
RSG
$63.9B
| $36.6M | 0.09% |
446,433
+422,060
| +1,732% | +$34M |
|
242
O'Reilly Automotive
ORLY
$74.9B
| $36.6M | 0.09% |
1,302,000
+1,500
| +0.1% | +$39.2K |
|
243
Ecolab
ECL
$79.7B
| $36.2M | 0.09% |
+182,171
| New | +$35.3M |
|
|
WBA
244
DELISTED
Walgreens Boots Alliance
WBA
| $36.2M | 0.09% |
852,997
-1,800
| -0.2% | -$76.4K |
|
245
SLB Ltd
SLB
$75.4B
| $36M | 0.09% |
1,960,067
+1,636,200
| +505% | +$28.7M |
|
246
PG&E
PCG
$38.4B
| $35.9M | 0.09% |
+4,050,000
| New | +$44.1M |
|
247
Marathon Petroleum
MPC
$91.3B
| $35.5M | 0.09% |
949,310
-669,800
| -41% | -$21.5M |
|
248
Eli Lilly
LLY
$995B
| $34.9M | 0.09% |
212,651
-655,400
| -76% | -$101M |
|
249
Ardelyx
ARDX
$1.24B
| $34.6M | 0.09% |
5,000,000
-263,685
| -5% | -$1.83M |
|
250
Algonquin Power & Utilities
AQN
$4.46B
| $34.3M | 0.09% |
2,650,000
-400,000
| -13% | -$5.47M |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.